positive living with MS
Please select your professional status below if you are a medical professional or click here to return to the msactivesource.co.uk website if you are not.
Clicking on the relevant title certifies that you are a healthcare professional accessing in your capacity as a healthcare professional.
MS Nurse...click here
Nurse...click here
Doctor...click here
MS Specialist...click here
You are leaving www.msactivesource.co.uk, a web site of Biogen Idec UK & Ireland. Links to all outside web sites are provided as a resource to our visitors. Biogen Idec accepts no responsibility for the content of other web sites.
|
|
Interferons are proteins that are found naturally in the body. There are three types - interferon alpha, interferon beta and interferon gamma. Interferons are produced by the immune system, they help to control viral infections and repair any damage that may result. However, the interferons have different effects on inflammation (swelling) in the body. Interferon alpha and interferon beta both have a moderating effect while interferon gamma increases inflammation.
Interferon beta has proved the most useful of the three compounds in terms of the benefits for people with MS. Interferon betas used to treat MS are genetically engineered copies of the proteins that occur in the body. They are injected under the skin (subcutaneous administration) or into a muscle (intramuscular administration). The table below summarises the different types available:
| Generic name | Brand name
|
Administration |
| Interferon beta-1a | Avonex | Intramuscular injection once a week |
| Interferon beta-1a | Rebif
|
Subcutaneous injections three times a week |
| Interferon beta-1b | Betaferon | Subcutaneous injection every other day |
Interferon beta acts in a number of ways to moderate the effect of MS on the body by helping to:
People with different types of MS respond differently to treatment with interferon beta. People with relapsing remitting MS seem to benefit the most. Studies show that in this group of people interferon beta reduces the number of relapses a person has by about a third. Some studies also show that interferon beta reduces the severity of relapses. (refT14)
Some people with secondary progressive MS may also benefit from treatment with interferon beta, but only if their relapses are the cause of increasing disability. People who are already disabled by MS and are unable to walk are unlikely to benefit.
Unfortunately people with primary progressive MS are not helped by treatment with interferon beta.
How MS affects you will be very different to how it affects someone else.
Supported by
This website is intended for use in Great Britain and Northern Ireland.
Please click here for msactivesource.ie
Page last updated: 14 Jul 2009
|
| This site complies to the HONcode standard for trustworthy health information: verify here. |